BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Healthcare Stocks PGEN and MLYS Double in Value, Analysts Predict Further Gains
Healthcare Stocks PGEN and MLYS Double in Value, Analysts Predict Further Gains
13
2
BTCCSquare news:
Precigen (PGEN) and another healthcare stock (MLYS) have surged over 100% since late July, catching Wall Street's attention. Precigen's 155% rally followed FDA approval for its breakthrough immunotherapy Papzimeos—the first treatment for recurrent respiratory papillomatosis. The drug demonstrated durable efficacy, with 15 of 18 initial responders remaining surgery-free after two years.
Analysts see room for further upside despite the steep climbs. The healthcare sector continues to produce asymmetric opportunities, with targeted therapies commanding premium valuations. Market participants are rewarding innovation as regulatory pathways accelerate for high-impact treatments.
By:
